Background and Aims Studies are needed to determine the long-term effects of bariatric
surgery for patients with nonalcoholic steatohepatitis (NASH). We evaluated sequential liver …

Background & Aims The effects of bariatric surgery in patients with nonalcoholic fatty liver
disease (NASH) are not well established. We performed a prospective study to determine …

Background Observational studies suggest that bariatric–metabolic surgery might greatly
improve non-alcoholic steatohepatitis (NASH). However, the efficacy of surgery on NASH …

Background: Hepatic steatosis and nonalcoholic steatohepatitis (NASH) have been
increasingly implicated in the genesis of hepatic fibrosis and cirrhosis. However, no …

Background: Nonalcoholic fatty liver disease (NAFLD) is a common form of chronic liver
disease in the United States. It is commonly associated with the components of the …

Currently, there are no approved medications to treat patients with nonalcoholic
steatohepatitis (NASH) with fibrosis or cirrhosis. Although the management goal in these …

OBJECTIVE Non-alcoholic steatohepatitis (NASH) is an increasingly prevalent problem.
Treatment options are still under investigation. The primary aim of the study was to …

Background: Non-alcoholic steatohepatitis (NASH) is a clinicopathological entity
characterized by the presence of steatosis and lobular and/or portal inflammation with or …

Background: In patients with morbid obesity selected for bariatric surgery, previous studies
have shown a prevalence of NASH varying from 2.6% to 91%. The prevalence of NASH and …

Nonalcoholic steatohepatitis (NASH) is a stage of nonalcoholic fatty liver disease (NAFLD),
and in most patients, is associated with obesity and the metabolic syndrome. The current …